Skip to content

Oxyntomodulin, Mechanisms of Action in Relation to Appetite, Food Intake, Gastric Emptying and Energy Expenditure.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01232244
Enrollment
15
Registered
2010-11-02
Start date
2010-10-31
Completion date
2012-01-31
Last updated
2013-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incretin Action, Obesity

Keywords

Incretin hormones, Glucagon, Satiety, Hunger, Energy expenditure

Brief summary

Tiny molecules (hormones) are released from the bowels and other organs to the bloodstream in response to meals in order to orchestrate the metabolism. Oxyntomodulin, GLP-1 and glucagon are all known to regulate parameters such as appetite, food intake and induce weight loss. Therefore we want to investigate mechanistic relations between the three hormones.

Interventions

1 pmol/kg/min

3ng/kg/min

OTHEROxyntomodulin infusion

3 pmol/kg/min

OTHERGLP-1 and glucagon infusion

1 pmol/kg/min 3 ng/kg/min

OTHERPlacebo

NaCl 9 g/L infusion

Sponsors

University Hospital, Gentofte, Copenhagen
Lead SponsorOTHER

Eligibility

Sex/Gender
MALE
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Normal fasting plasma glucose * Normal glucose tolerance * Normal haemoglobin levels * Informed content

Exclusion criteria

* Diabetes * Pre diabetes (impaired glucose tolerance or impaired fasting glucose) * 1st degree relatives with diabetes * Obesity (BMI \> 30) * Inflammatory bowels disease * Bowels surgery * Nephropathy * Liver disease * Medication which cannot be on hold for 24h

Design outcomes

Primary

MeasureTime frameDescription
basal energy expenditure2 x 30minAssessed by indirect calorimetry
Gastric emptying4 hAssessed by the acetaminophen - method
Satiety4 hAssessed by VAS
Hunger4 hAssessed by an ad'libitum meal

Secondary

MeasureTime frame
GLP-14 h
Oxyntomodulin4 h
Glucagon4 h
GIP4 h

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026